Selected Grants
EFC17801_9085-0205 SANOFI Pro00113681
Clinical TrialPrincipal Investigator · Awarded by Sanofi US · 2024 - 2028Lung Transplant Clinical Trial Network (LT-CTN)
ResearchCo Investigator · Awarded by National Institutes of Health · 2021 - 2028Complement Pathway Activation in Idiopathic Pulmonary Fibrosis and other Progressive Fibrosing Interstitial Lung Diseases (K23)
ResearchAdvisor · Awarded by National Institutes of Health · 2023 - 2028Duke Program of Training in Pulmonary ReSearch to Promote, Engage and Retain Academic Researchers (PROSPER)
Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 2022 - 2026Long Term Follow up of the Lung Transplant Outcomes Group Cohort
ResearchCo Investigator · Awarded by University of Pennsylvania · 2019 - 2026EFC17801_9085-0205 SANOFI Pro00113681
Clinical TrialPrincipal Investigator · Awarded by Sanofi US · 2024 - 2028Lung Transplant Clinical Trial Network (LT-CTN)
ResearchCo Investigator · Awarded by National Institutes of Health · 2021 - 2028Complement Pathway Activation in Idiopathic Pulmonary Fibrosis and other Progressive Fibrosing Interstitial Lung Diseases (K23)
ResearchAdvisor · Awarded by National Institutes of Health · 2023 - 2028Duke Program of Training in Pulmonary ReSearch to Promote, Engage and Retain Academic Researchers (PROSPER)
Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 2022 - 2026Long Term Follow up of the Lung Transplant Outcomes Group Cohort
ResearchCo Investigator · Awarded by University of Pennsylvania · 2019 - 2026Secondary Analyses to Support the Rational Design of Clinical Trials in Chronic Lung Allograft Dysfunction
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2023 - 2025Evaluating PFT trends for the development of Baseline Lung Allograft Dysfunction after lung transplantation
ResearchCollaborator · Awarded by International Society for Heart & Lung Transplantation · 2024 - 2024Club cell secretory protein to distinguish chronic allograft dysfunction risk in lung transplant recipients
ResearchPrincipal Investigator · Awarded by Cystic Fibrosis Foundation · 2023 - 2024Early Posttransplant Intragraft Hyaluronan as an Independent Biomarker of CLAD Risk
ResearchPrincipal Investigator · Awarded by Cystic Fibrosis Foundation · 2022 - 2024CTOT Long-Term Extension Study
ResearchCo Investigator · Awarded by Cystic Fibrosis Foundation · 2019 - 2024Cell-free DNA in the Blood and Lung Allograft Fluid: Understanding Association with Acute Rejection in Lung Transplant Recipients
ResearchCo Investigator · Awarded by CareDx, Inc. · 2019 - 2023Chronic Lung Allograft Dysfunction
ResearchCo Investigator · Awarded by AstraZeneca AB · 2019 - 2023Genetics of Acute Rejection and Chronic Lung Allograft Dysfunction
ResearchCo Investigator · Awarded by Cystic Fibrosis Foundation · 2019 - 2022Club Cells and CCSP in the pathogenesis of CLAD/spatial transcriptomics
ResearchCo Investigator · Awarded by Icahn School of Medicine at Mount Sinai · 2020 - 2021Hyaluronan in Acute Rejection and Chronic Allograft Dysfunction after Lung Transplantation - CTOT Ancillary
ResearchPrincipal Investigator · Awarded by Mount Sinai School of Medicine · 2019 - 2021Immune Profiles to Better Understand Chronic Allograft Dysfunction and Successful Long-term Clinical Outcomes after Human Lung Transplantation
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2016 - 2021Lung Tissue Gene Expression Profiling in Chronic Lung Allograft Dysfunction-CTOT
ResearchPrincipal Investigator · Awarded by Mount Sinai School of Medicine · 2018 - 2019CTOT Ancillary Studies Fund Carry Forward BAL
ResearchCo-Principal Investigator · Awarded by Mount Sinai School of Medicine · 2016 - 2017CTOT - Cell Free DNA
ResearchCollaborator · Awarded by Mount Sinai School of Medicine · 2016 - 2017Hyaluronan in Acute Rejection and Chronic Lung Allograft Dysfunction after Human Lung Transplantation
ResearchPrincipal Investigator · Awarded by Mount Sinai School of Medicine · 2016 - 2017CTOT Ancillary Studies Fund
ResearchCo-Principal Investigator · Awarded by Mount Sinai School of Medicine · 2014 - 2016Blood-SCAN feasibility Phase 3
ResearchPrincipal Investigator · Awarded by Harvard Pilgrim Health Care, Inc. · 2013 - 2016External Relationships
- Avalyn
- Sanofi
- Theravance, Inc
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.